Otsuka Pharmaceutical Development & Commercialization, Inc.

This study is testing whether a new injectable drug called sibeprenlimab can help control the underlying disease activity and ease symptoms of Sjögren's. About 80 adults with active Sjögren's disease will receive either the drug or a placebo injection every four weeks, in additio…

This large, late-stage study is testing whether a new injectable drug called sibeprenlimab can help people with IgA nephropathy, an autoimmune kidney disease. About 530 adults with confirmed disease will receive either the drug or a placebo shot every 4 weeks for up to 2 years. T…

This study aimed to see if a drug called tolvaptan could help babies with a rare, serious genetic kidney disease (ARPKD) by delaying the need for dialysis or transplant. It planned to give the drug to infants under 12 weeks old for two years and track their kidney health. The tri…

This study aims to check the long-term safety and side effects of a daily ADHD medication called centanafadine in children and adolescents aged 4 to 17. About 680 participants will take the medication for at least one year. The main goal is to see how well kids tolerate the drug …